The tumor suppressor RASSF1A in human carcinogenesis: an update.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Histology and Histopathology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.14670/HH-20.645PMID 15736067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor susceptibility of Rassf1a knockout mice.

  2005cited by this paper
• Alterations of cancer‐related genes in soft tissue sarcomas: Hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma

  2005cited by this paper
• Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.

  2005cited by this paper
• DNA‐methylation analysis identifies the E‐cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies

  2004cited by this paper
• Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest

  2004cited by this paper
• Tumor Cell-Specific BRCA1 and RASSF1A Hypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

  2004cited by this paper
• Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.

  2004cited by this paper
• A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability

  2004cited by this paper
• Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma

  2004cited by this paper
• RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma

  2004cited by this paper
• Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung

  2004cited by this paper
• Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

  2004cited by this paper
• Ubiquitous Aberrant RASSF1A Promoter Methylation in Childhood Neoplasia1

  2004cited by this paper
• Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation

  2004cited by this paper
• Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients

  2004cited by this paper
• Dose effect of smoking on aberrant methylation in non‐small cell lung cancers

  2004cited by this paper
• Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.

  2004cited by this paper
• SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma

  2004cited by this paper
• CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer

  2004cited by this paper
• Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma

  2004cited by this paper
• Promoter Hypermethylation of Resected Bronchial Margins

  2004cited by this paper
• Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases

  2004cited by this paper
• Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel

  2004cited by this paper
• Identification of the E1A-Regulated Transcription Factor p120E4F as an Interacting Partner of the RASSF1A Candidate Tumor Suppressor Gene

  2004cited by this paper
• The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex

  2004cited by this paper
• Methylated DNA collected by tampons--a new tool to detect endometrial cancer.

  2004cited by this paper
• Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia

  2004cited by this paper
• Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas

  2004cited by this paper
• Differential Methylation Status of Tumor-Associated Genes in Head and Neck Squamous Carcinoma

  2004cited by this paper
• Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma

  2004cited by this paper
• Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas

  2004cited by this paper
• Linking tumor suppression, DNA damage and the anaphase-promoting complex.

  2004cited by this paper
• Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

  2004cited by this paper
• RASSF1A, the new guardian of mitosis

  2004cited by this paper
• The Contribution of Genetic and Epigenetic Changes in Granulosa Cell Tumors of Ovarian Origin

  2004cited by this paper
• A survey of gene-specific methylation in human prostate cancer among black and white men.

  2004cited by this paper
• Detection of Breast Cancer in Nipple Aspirate Fluid by CpG Island Hypermethylation

  2004cited by this paper
• Heterogeneous gene methylation patterns among pre‐invasive and cancerous lesions of the prostate: A histopathologic study of whole mount prostate specimens

  2004cited by this paper
• Novel Functional Interaction between the Plasma Membrane Ca2+ Pump 4b and the Proapoptotic Tumor Suppressor Ras-associated Factor 1 (RASSF1)*

  2004cited by this paper
• Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia

  2004cited by this paper
• Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene

  2004cited by this paper
• Promoter Hypermethylation Profile of Kidney Cancer

  2004cited by this paper
• The Scaffold Protein CNK1 Interacts with the Tumor Suppressor RASSF1A and Augments RASSF1A-induced Cell Death*

  2004cited by this paper
• Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid Tumorigenesis

  2004cited by this paper
• Detection of Promoter Hypermethylation of Multiple Genes in the Tumor and Bronchoalveolar Lavage of Patients with Lung Cancer

  2004cited by this paper
• RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics

  2004cited by this paper
• NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers

  2003cited by this paper
• Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients

  2003cited by this paper
• Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

  2003cited by this paper
• DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma

  2003cited by this paper
• Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer.

  2003cited by this paper
• Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers

  2003cited by this paper
• DNA methylation in serum of breast cancer patients: an independent prognostic marker.

  2003cited by this paper
• RASSF1A gene inactivation in non‐small cell lung cancer and its clinical implication

  2003cited by this paper
• Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.

  2003cited by this paper
• Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient

  2003cited by this paper
• Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.

  2003cited by this paper
• Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors

  2003cited by this paper
• Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation.

  2003cited by this paper
• Inactivation of the RASSF1A in osteosarcoma.

  2003cited by this paper
• Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.

  2003cited by this paper
• Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers

  2003cited by this paper
• RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer.

  2003cited by this paper
• Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.

  2003cited by this paper
• Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.

  2003cited by this paper
• Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.

  2003cited by this paper
• Promoter hypermethylation of tumor suppressor and tumor‐related genes in non‐small cell lung cancers

  2003cited by this paper
• Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.

  2003cited by this paper
• Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.

  2003cited by this paper
• The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas.

  2003cited by this paper
• Epigenetic inactivation of RASSF1A in head and neck cancer.

  2003cited by this paper
• Serum DNA as a tool for cancer patient management.

  2003cited by this paper
• Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.

  2003cited by this paper
• O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

  2003cited by this paper
• Control of microtubule stability by the RASSF1A tumor suppressor

  2003cited by this paper
• Alterations of RAS signalling in Chinese multiple myeloma patients: absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non‐functional variant transcript

  2003cited by this paper
• Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples

  2003cited by this paper
• Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma

  2003cited by this paper
• Differential gene methylation in undifferentiated nasopharyngeal carcinoma.

  2003cited by this paper
• Multipoint methylation analysis indicates a distinctive epigenetic phenotype among testicular germ cell tumors and testicular malignant lymphomas

  2003cited by this paper
• Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.

  2003cited by this paper
• The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung*

  2003cited by this paper
• Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms

  2003cited by this paper
• The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

  2003cited by this paper
• Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients

  2003cited by this paper
• Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis.

  2003cited by this paper
• Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.

  2003cited by this paper
• Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours

  2003cited by this paper
• Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma

  2003cited by this paper
• Profile of Aberrant CpG Island Methylation along Multistep Gastric Carcinogenesis

  2003cited by this paper
• Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

  2003cited by this paper
• Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

  2002cited by this paper
• Methylation of the RASSF1A Gene in Human Cancers

  2002cited by this paper
• Patterns of gene promoter methylation in squamous cell cancer of the head and neck

  2002cited by this paper
• Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor rassf1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cells

  2002cited by this paper
• K-ras mutations and RASSF1A promoter methylation in colorectal cancer

  2002cited by this paper
• Quantitative assessment of promoter hypermethylation during breast cancer development.

  2002cited by this paper
• The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

  2002cited by this paper

• Advances in Gastric Cancer Management: Signaling Pathways, Emerging Diagnostic and Therapeutic Strategies.

  2025cites this paper
• Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth

  2023cites this paper
• Regulation of Ras p21 and RalA GTPases activity by quinine in mammary epithelial cells

  2023cites this paper
• DNA methylation in the genesis, progress and prognosis of head and neck cancer

  2023cites this paper
• Expression of Extracellular Regulated Protein Kinase (ERK) & Promoter Methylation of RASSF1A In Endometrioid Endometrial Carcinoma and Its Precursor Lesions – A Nested Case Control Study and Review of Literature

  2023cites this paper
• Use of Publication Dynamics to Distinguish Cancer Genes and Bystander Genes

  2022cites this paper
• DNA methylation influences the CTCF‐modulated transcription of RASSF1A in lung cancer cells

  2022cites this paper
• Emerging patterns and implications of breast cancer epigenetics

  2021cites this paper
• Proteomics analysis of tissue small extracellular vesicles reveals protein panels for the reoccurrence prediction of colorectal cancer.

  2021cites this paper
• Identification of Candidate Genes in Early-Stage Invasive Ductal Carcinoma Patients with High-Risk Mortality Using Genes Commonly Involved in Breast Cancer: A Retrospective Study

  2021cites this paper
• The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma

  2021influential citation
• Epigenetically inactivated RASSF 1 A as a tumor biomarker

  2021cites this paper
• RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)

  2020cites this paper
• Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1

  2020cites this paper
• Epigenetically inactivated RASSF1A as a tumor biomarker

  2020cites this paper
• Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing

  2020cites this paper
• Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential

  2020cites this paper
• DNA methylation patterns of RAR‐β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions

  2020cites this paper
• Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases.

  2020cites this paper
• RETRACTED: Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A

  2019cites this paper
• Epigenomic adaptations of exercise in the control of metabolic disease and cancer

  2019cites this paper
• Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.

  2019cites this paper
• The long non-coding RNA ANRASSF1 in the regulation of alternative protein-coding transcripts RASSF1A and RASSF1C in human breast cancer cells: implications to epigenetic therapy

  2019cites this paper
• RASSF1A–Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target

  2019cites this paper
• Suppressive efficiency of RASSF1A in endometrial carcinoma via inhabiting estrogen receptor alpha expression and ERK pathway activation.

  2018cites this paper
• Defining Driver DNA Methylation Changes in Human Cancer

  2018cites this paper
• Identification of methylation sites and signature genes with prognostic value for luminal breast cancer

  2018cites this paper
• Promoter Methylation of RASSF1A Gene in Egyptian Patients with Ovarian Cancer

  2018cites this paper
• PNMA family: Protein interaction network and cell signalling pathways implicated in cancer and apoptosis.

  2018cites this paper
• Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update

  2017cites this paper
• Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA)

  2017cites this paper
• Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients

  2017cites this paper
• WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.

  2017cites this paper
• Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis.

  2017cites this paper
• Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer

  2017cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Transcription Factors, Signal Pathways Regulating Proliferation and Apoptosis, and Telomeres/Telomerases

  2017cites this paper
• DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification

  2016cites this paper
• RASSF 1 A inhibits gastric cancer cell proliferation by miR-711-mediated downregulation of CDK 4 expression

  2016cites this paper
• Femtomolar level detection of RASSF1A tumor suppressor gene methylation by electrochemical nano-genosensor based on Fe3O4/TMC/Au nanocomposite and PT-modified electrode.

  2016cites this paper
• Original article: DNA METHYLATION ASSESSMENT AS A PROGNOSTIC FACTOR IN INVASIVE BREAST CANCER USING METHYLATION-SPECIFIC MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION

  2016cites this paper
• DNA Methylation and Its Effect on Various Cancers: An Overview

  2016cites this paper
• Using Zinc Finger Proteins as a Diagnostic Tool for the Detection of a Cancer Biomarker

  2016cites this paper
• RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expression

  2016cites this paper
• Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.

  2016cites this paper
• RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1

  2016cites this paper
• Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men.

  2016cites this paper
• The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway

  2016cites this paper
• Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis

  2016cites this paper
• The Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer

  2016cites this paper
• Anti-inflammatory, epigenetic regulatory role of phytochemicals and pkpd modeling of pharmacological effects

  2016cites this paper
• Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer

  2016cites this paper
• Methylation of the RASSFIA promoter in breast cancer.

  2016cites this paper
• Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

  2016cites this paper
• Malignant Rhabdoid Tumors and Tumors with Rhabdoid Features

  2016cites this paper
• CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers.

  2015cites this paper
• Promoter methylation of p 16 and RASSF 1 A genes may contribute to the risk of papillary thyroid cancer : A meta-analysis

  2015cites this paper
• Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.

  2015cites this paper
• Regulation of the retinoblastoma tumor suppressor by the novel Ras effector NORE1A.

  2015cites this paper
• The Tumor Suppressor RASSF1A Links Inflammation and Cancer

  2015cites this paper
• Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi

  2015cites this paper
• Methylation biomarkers for pleomorphic lobular breast cancer - a short report

  2015cites this paper
• Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma

  2015cites this paper
• Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thyroid cancer: A meta-analysis.

  2015cites this paper
• Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics.

  2015cites this paper
• Methylation in the regulation of the expression of chromosome 3 and microRNA genes in clear-cell renal cell carcinomas

  2015cites this paper
• Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

  2014cites this paper
• Molecular Testing in Prostate Cancer

  2014cites this paper
• Cell Cycle Restriction Is More Important Than Apoptosis Induction for RASSF1A Protein Tumor Suppression*

  2014cites this paper
• Protein Tumor Suppression Than Apoptosis Induction for RASSF 1 A Cell Cycle Restriction Is More Important Cell Biology

  2014cites this paper
• Methylation Status of Tumor-Related Genes in Mcf7, Mda-Mb-468 and Bt-474 Breast Cancer Cell Lines with Different Estrogen Receptor Status

  2014cites this paper
• Pathogenetic mechanisms in gastric cancer.

  2014cites this paper
• DNA Methylation as a Biomarker in Nasopharyngeal Carcinoma

  2014cites this paper
• Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma

  2014cites this paper
• The RASSF1A Tumor Suppressor Regulates XPA-Mediated DNA Repair

  2014cites this paper
• Early molecular changes in arsenic exposed human urothelial cells depending on cellular uptake and biotransformation

  2014influential citation
• Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer

  2014cites this paper
• Novel Therapeutic Approaches for Inflammatory Bowel disease

  2014cites this paper
• β-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expression

  2014cites this paper
• Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer

  2013cites this paper
• Mitotic Arrest by Tumor Suppressor RASSF1A Is Regulated via CHK1 Phosphorylation

  2013cites this paper
• Genetic and Epigenetic Abnormalities in Primary Sclerosing Cholangitis-associated Cholangiocarcinoma

  2013cites this paper
• Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients

  2013cites this paper
• Oncogenes and Tumor Suppressors Mitotic Arrest by Tumor Suppressor RASSF 1 A Is Regulated via CHK 1 Phosphorylation

  2013cites this paper
• Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.

  2013cites this paper
• Patró de metilació d'un panell de biomarcadors en l'adenocarcinoma pulmonar

  2013cites this paper
• RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.

  2013cites this paper
• RASSF1A: a potential novel therapeutic target against cardiac hypertrophy.

  2013cites this paper
• Acquired Genetic and Epigenetic Alterations in Nasopharyngeal Carcinoma

  2013cites this paper
• Genomewide DNA Methylation Analysis Identifies Novel Methylated Genes in Non–Small-Cell Lung Carcinomas

  2013cites this paper
• C. elegans Rassf homolog, rasf‐1, is functionally associated with rab‐39 Rab GTPase in oxidative stress response

  2013cites this paper
• Natural Products in Cancer Prevention and Therapy

  2013cites this paper
• 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.

  2013cites this paper
• Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.

  2012cites this paper
• Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome

  2012cites this paper
• RASSF1A and the Taxol Response in Ovarian Cancer

  2012cites this paper
• The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C

  2012cites this paper
• RASSF1 Polymorphisms in Cancer

  2012cites this paper
• Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report

  2012cites this paper
• RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development

  2012cites this paper
• Cancer Chemoprevention and Nutri-Epigenetics : State of the Art and Future Challenges

  2012cites this paper